Research and Development Summary
Molecular Biometrics’ (MB) research and development mission is to determine the underlying effect of health conditions on the metabolism of biological systems. An organism’s physiologic state is defined by a unique, complex array of small molecule biomarkers that make up the metabolome at the cellular level. Molecular Biometrics develops technologies that can identify and quantify these biomarkers and rapidly sort through vast amounts of data, developing novel “metabolomic profiles” or “fingerprints” of normal or abnormal cellular function.
Focus is placed on four important fields of medicine: Reproductive Health and Infertility, Neurodegenerative Diseases, Maternal Fetal Medicine, and Lactate and Pulmonary Metabolism. Within each of these fields, metabolomic profiles are developed by the non-invasive analysis of target biological fluids.
A brief list of biological fluids analyzed by Molecular Biometrics includes:
Reproductive Health and Infertility – Follicular fluid, seminal plasma, embryo culture media (cleavage, blastocyst)
Neurodegenerative Diseases – Blood plasma
Maternal Fetal Medicine – Amniotic fluid
Lactate and Pulmonary Metabolism – Various tissues
Metabolomic profiles of these biological fluids are then systematically analyzed to distinguish between the often subtle differences that separate normal physiology from the onset or progression of disease, or an individual’s response to therapeutic intervention.
For more detail and related topics, proceed to Biospectroscopy Based Metabolomics.